Volume 16, Issue 4 (Jul-Aug 2022)                   mljgoums 2022, 16(4): 39-46 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nouri A, Farzanegi P, Azarbayjani M A. Effects of Resveratrol Supplementation and Exercise on Apoptosis, Lipid Profile, and Expression of Farnesoid X Receptor, Liver X Receptor and Sirtuin 1 Genes in the Liver of Type 1 Diabetic Rats. mljgoums. 2022; 16 (4) :39-46
URL: http://mlj.goums.ac.ir/article-1-1467-en.html
1- Department of Exercise Physiology, Faculty of Humanities, Sari Branch, Islamic Azad University, Sari, Iran
2- Department of Exercise Physiology, Faculty of Humanities, Sari Branch, Islamic Azad University, Sari, Iran , parvin.farzanegi@gmail.com
3- Department of Exercise Physiology, Islamic Azad University, Central Tehran Branch
Abstract:   (178 Views)
Background and objectives: Diabetes mellitus is the most common metabolic disorder in the world. Here, we evaluated effects of resveratrol supplementation alone and combined with exercise on blood glucose, insulin, lipid profile, apoptosis biomarkers, and expression of farnesoid X receptor (Fxr), liver X receptor (Lxr), and sirtuin 1 (Sirt 1) genes in the liver of type 1 diabetic rats.
Methods: Streptozotocin was used to induce type 1 diabetes in Wistar rats. The rats were randomly assigned into seven groups. After treatment with resveratrol alone or combined with exercise training, the animals were sacrificed and lipid profile and levels of blood glucose and insulin were measured. Hepatocyte apoptosis was assessed by measuring the level of Bax and Bcl2 proteins using enzyme-linked immunosorbent assay kits. Expression of Fxr, Lxr, and Sirt1 was evaluated using real-time polymerase chain reaction. Comparison of the mean levels of all variables between different groups was performed using one-way analysis of variance, at statistical significance level of 0.05.
Results: Resveratrol significantly reduced the level of blood glucose and insulin compared with the control groups (p<0.001). It also significantly affected the lipid profile (p<0.001). Diabetes was significantly associated with decreased expression of Sirt1, Lxr, and Fxr and increased hepatocyte apoptosis. Resveratrol significantly improved the expression of all three genes (p<0.01). Overall, resveratrol supplementation combined with exercise was more effective than other methods.
Conclusion: The results indicate that that combination of resveratrol therapy with exercise could be beneficial for diabetic patients. However, more studies are needed to confirm this finding.
Full-Text [PDF 816 kb]   (44 Downloads) |   |   Full-Text (HTML)  (21 Views)  
Research Article: Original Paper | Subject: Sport Physiology
Received: 2021/12/15 | Accepted: 2022/02/12 | Published: 2022/07/16 | ePublished: 2022/07/16

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94(3): 311-21. [DOI:10.1016/j.diabres.2011.10.029] [PubMed]
2. Barbot M, Ceccato F, Scaroni C. Diabetes Mellitus Secondary to Cushing's Disease. Front Endocrinol (Lausanne). 2018;9:284. [View at Publisher] [DOI:10.3389/fendo.2018.00284] [PubMed] [Google Scholar]
3. Fletcher B, Gulanick M, Lamendola C. Risk factors for type 2 diabetes mellitus. J Cardiovasc Nurs. 2002;16:17-23. [DOI:10.1097/00005082-200201000-00003] [PubMed] [Google Scholar]
4. Kitada M, Koya D. SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential. Diabetes Metab J. 2013;37:315-25. [View at Publisher] [DOI:10.4093/dmj.2013.37.5.315] [PubMed] [Google Scholar]
5. Kong B, Luyendyk P, Tawfik O, Guo GL. Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet. The Journal of pharmacology and experimental therapeutics. 2009; 328: 116-22. [View at Publisher] [DOI:10.1124/jpet.108.144600] [PubMed] [Google Scholar]
6. Colak Y, Ozturk O, Senates E, Tuncer I, Yorulmaz E, Adali G, et al. SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Medical science monitor : international medical journal of experimental and clinical research. 2011; 17(5): HY5-9. [DOI:10.12659/MSM.881749] [PubMed] [Google Scholar]
7. Steffensen KR, Gustafsson JA. Putative Metabolic Effects of the Liver X Receptor (LXR). Diabetes. 2004;53:S36-S42. [View at Publisher] [DOI:10.2337/diabetes.53.2007.S36] [PubMed] [Google Scholar]
8. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nature reviews Drug discovery. 2006;5(6):493-506. [View at Publisher] [DOI:10.1038/nrd2060] [PubMed] [Google Scholar]
9. Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, Garcia-Urkia N, et al. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC gastroenterology. 2008;8:40. [View at Publisher] [DOI:10.1186/1471-230X-8-40] [PubMed] [Google Scholar]
10. Singh CK, George J, Ahmad N. Resveratrol-based combinatorial strategies for cancer management. Annals of the New York Academy of Sciences. 2013;1290:113-21. [View at Publisher] [DOI:10.1111/nyas.12160] [PubMed] [Google Scholar]
11. Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G, Fuggetta MP. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation. 2012;35(1):240-8. [View at Publisher] [DOI:10.1007/s10753-011-9310-z] [PubMed] [Google Scholar]
12. Abba Y, Hassim H, Hamzah H, Noordin MM. Antiviral Activity of Resveratrol against Human and Animal Viruses. Advances in virology. 2015;2015:184241. [View at Publisher] [DOI:10.1155/2015/184241] [PubMed] [Google Scholar]
13. Hajighasem A, Farzanegi P, Mazaheri Z. Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease. Arch Physiol Biochem. 2019; 125(2): 142-149. [View at Publisher] [DOI:10.1080/13813455.2018.1441872] [PubMed] [Google Scholar]
14. Chicco AJ, Hydock DS, Schneider CM, Hayward R. Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity. Journal of applied physiology. 2006; 100(2): 519-27. [View at Publisher] [DOI:10.1152/japplphysiol.00148.2005] [PubMed] [Google Scholar]
15. Park SY, Kwak YS. Impact of aerobic and anaerobic exercise training on oxidative stress and antioxidant defense in athletes. Journal of exercise rehabilitation. 2016; 12(2): 113-7. [DOI:10.12965/jer.1632598.299] [PubMed] [Google Scholar]
16. Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi SH, Farhangi A, Allah Verdi A, et al. Induction of diabetes by Streptozotocin in rats. Indian J Clin Biochem. 2007; 22: 60-4. [View at Publisher] [DOI:10.1007/BF02913315] [PubMed] [Google Scholar]
17. Batacan RB, Jr., Duncan MJ, Dalbo VJ, Connolly KJ, Fenning AS. Light-intensity and high-intensity interval training improve cardiometabolic health in rats. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 2016;41(9):945-52. [DOI:10.1139/apnm-2016-0037] [PubMed] [Google Scholar]
18. Freitas DA, Rocha-Vieira E, Soares BA, Nonato LF, Fonseca SR, Martins JB, et al. High intensity interval training modulates hippocampal oxidative stress, BDNF and inflammatory mediators in rats. Physiology & behavior. 2017;184:6-11. [View at Publisher] [DOI:10.1016/j.physbeh.2017.10.027] [PubMed] [Google Scholar]
19. Ma Z, Chu L, Liu H, Wang W, Li J, Yao W, et al. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Scientific reports. 2017;7:44819. [View at Publisher] [DOI:10.1038/srep44819] [PubMed] [Google Scholar]
20. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, et al. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes. 2004; 53: 890-8. [View at Publisher] [DOI:10.2337/diabetes.53.4.890] [PubMed] [Google Scholar]
21. Zhang HM, Wang X, Wu ZH, Liu HL, Chen W, Zhang ZZ, et al. Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model. Molecular medicine reports. 2016; 13: 2135-42. [DOI:10.3892/mmr.2016.4761] [PubMed] [Google Scholar]
22. Ma K, Saha PK, Chan L, Moore DD. Farnesoid X receptor is essential for normal glucose homeostasis. The Journal of clinical investigation. 2006;116:1102-9. [DOI:10.1172/JCI25604] [PubMed] [Google Scholar]
23. Nascimento AF, Ip BC, Luvizotto RA, Seitz HK, Wang XD. Aggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in rats. Hepatobiliary surgery and nutrition. 2013;2(5):252-9. [PubMed] [Google Scholar]
24. Wang XH, Zhu L, Hong X, Wang YT, Wang F, Bao JP, et al. Resveratrol attenuated TNF-alpha-induced MMP-3 expression in human nucleus pulposus cells by activating autophagy via AMPK/SIRT1 signaling pathway. Experimental biology and medicine. 2016;241(8):848-53. [View at Publisher] [DOI:10.1177/1535370216637940] [PubMed] [Google Scholar]
25. Goh KP, Lee HY, Lau DP, Supaat W, Chan YH, Koh AF. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure. International journal of sport nutrition and exercise metabolism. 2014;24(1):2-13. [DOI:10.1123/ijsnem.2013-0045] [PubMed] [Google Scholar]
26. Sevov M, Elfineh L, Cavelier LB. Resveratrol regulates the expression of LXR-alpha in human macrophages. Biochemical and biophysical research communications. 2006;348(3):1047-54. [View at Publisher] [DOI:10.1016/j.bbrc.2006.07.155] [PubMed] [Google Scholar]
27. Chen S, Xiao X, Feng X, Li W, Zhou N, Zheng L, et al. Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression. J Nutr Biochem. 2012; 23(9):1100-1112. [View at Publisher] [DOI:10.1016/j.jnutbio.2011.06.003] [PubMed] [Google Scholar]
28. Liao ZY, Chen JL, Xiao MH, Sun Y, Zhao YX, Pu D, et al. The effect of exercise, resveratrol or their combination on Sarcopenia in aged rats via regulation of AMPK/Sirt1 pathway. Experimental Gerontology. Experimental Gerontology. 2017; 98; 177-183. [View at Publisher] [DOI:10.1016/j.exger.2017.08.032] [PubMed] [Google Scholar]
29. Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutrition research. 2014;34(10):837-43. [View at Publisher] [DOI:10.1016/j.nutres.2014.09.005] [PubMed] [Google Scholar]
30. Tung BT, Rodriguez-Bies E, Thanh HN, Le-Thi-Thu H, Navas P, Sanchez VM, et al. Organ and tissue-dependent effect of resveratrol and exercise on antioxidant defenses of old mice. Aging clinical and experimental research. 2015;27(6):775-83. [View at Publisher] [DOI:10.1007/s40520-015-0366-8] [PubMed] [Google Scholar]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.